Patient 'progressing' after first artificial heart implant in France

December 22, 2013 by Laurence Benhamou

A 75-year-old man who this week became the first person to receive an artificial heart developed by French biomedical firm Carmat was progressing well, doctors said Saturday.

The patient was "progressing and recuperating", said surgeon Christian Latremouille, who was among the 16-strong team of doctors who performed the operation at the Georges Pompidou Hospital in Paris on Wednesday.

Artificial hearts have already been in use for many years as a temporary fix for patients with chronic heart problems.

The Carmat product aims at providing a longer-term solution to bridge the wait for a donor heart and enable hospitalised patients to return home and maybe even resume work.

"He was nearing the end of his life," Latremouille told a press conference, adding that the surgery had gone according to plan. "The intervention took place in good conditions... There were no complications linked to the innovative nature of the implant operation," he said.

"He is not walking yet, but we will try to get him sitting and then standing soon enough. The objective is for him to have a normal life."

The artificial heart, a self-contained unit implanted in the patient's chest, uses soft "biomaterials" and an array of sensors to mimic the contractions of the heart.

The goal is to lessen the risk of blood clots and rejection by the immune system.

The patient will have to wear a belt of lithium batteries to power the heart.

Cardiac surgeon Alain Carpentier, who led the operation and who has spent 25 years working on the development of the artificial heart, said he was grateful to the patient for taking part in the trial. "He has a lot of humour. He's a very good patient," he told reporters.

More volunteers could soon benefit from the 900-gramme (31-ounce) device, according to Philippe Pouletty, who co-founded Carmat with Carpentier.

"A number of patients are being selected. It is likely that other implantations will take place in the coming weeks," he told Europe 1 radio.

The first phase of the trial, on a small group of volunteers in terminal condition, will assess survival one month after the operation, or earlier if the patient receives a natural heart.

"France can be proud of this exceptional effort in the service of human progress," French President Francois Hollande said in a congratulatory letter to the medical team.

Prime Minister Jean-Marc Ayrault turned to Twitter to praise the achievement. "Thank you for the hope and prospects that this feat brings," he wrote.

Nearly 100,000 people in Europe and the United States are in need of a heart transplant, according to Carmat.

A US rival to Carmat, an called AbioCor, is authorised in the United States for patients with end-stage heart failure or life expectancy of less than 30 days, who are not eligible for a natural heart plant and have no other viable treatment options.

Explore further: French firm starts human trials of artificial heart

Related Stories

French firm starts human trials of artificial heart

December 20, 2013
French biomedical firm Carmat said on Friday it had begun the first human trial of its prototype artificial heart, which aims at overcoming shortages of organs available for transplant.

Artificial heart with Norwegian sensor

December 19, 2013
France is going to test an artificial heart on patients. The heart will contain a Norwegian pressure sensor.

Space technology informs artificial heart development

December 6, 2013
An artificial heart containing miniaturised space technology will soon beat inside a person, having now been approved for human trials in France.

Heart surgery mortality rates significantly reduced

November 25, 2013
Fifty years have passed since the first heart operation was carried out with a heart-lung machine at the MedUni Vienna in the Vienna General Hospital. Since then cardiac surgery has developed at an astonishing rate – to ...

UCLA doctors remove man's heart, replace it with total artificial heart

December 7, 2012
Imagine living without a heart. It is possible—if you have a new artificial heart pumping blood through your body. You can even go to the supermarket, watch your kid's soccer game or go on a hike.

Recommended for you

Could aggressive blood pressure treatments lead to kidney damage?

July 18, 2017
Aggressive combination treatments for high blood pressure that are intended to protect the kidneys may actually be damaging the organs, new research from the University of Virginia School of Medicine suggests.

Quantifying effectiveness of treatment for irregular heartbeat

July 17, 2017
In a small proof-of-concept study, researchers at Johns Hopkins report a complex mathematical method to measure electrical communications within the heart can successfully predict the effectiveness of catheter ablation, the ...

Concerns over side effects of statins stopping stroke survivors taking medication

July 17, 2017
Negative media coverage of the side effects associated with taking statins, and patients' own experiences of taking the drugs, are among the reasons cited by stroke survivors and their carers for stopping taking potentially ...

Study discovers anticoagulant drugs are being prescribed against safety advice

July 17, 2017
A study by researchers at the University of Birmingham has shown that GPs are prescribing anticoagulants to patients with an irregular heartbeat against official safety advice.

Protein may protect against heart attack

July 14, 2017
DDK3 could be used as a new therapy to stop the build-up of fatty material inside the arteries

Heart study finds faulty link between biomarkers and clinical outcomes

July 14, 2017
Surrogate endpoints (biomarkers), which are routinely used in clinical research to test new drugs, should not be trusted as the ultimate measure to approve new health interventions in cardiovascular medicine, according to ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.